Artesunate induces ferroptosis in osteosarcoma through NCOA4-mediated ferritinophagy.
Artesunate (ART) has been proved to have remarkable treatment effects on severe malaria and anti-tumor properties.
Bone Cancer · LIVING RESEARCH LIBRARY
Ongoing Research for Bone Cancer Using Advanced Alternative Medicine
Explore positive published findings by substance, cancer biology, treatment interaction and quality-of-life outcome.
Every entry includes the original study title, year, concise finding and a direct PubMed link.
Call 1.800.923.7878Ask About Your Bone Cancer Case
Tell us the diagnosis, stage, biomarkers, current treatment plan and research questions you want to understand. Our Patient Care Team will follow up personally.
Prefer to speak now?
Call 1.800.923.7878
Living research library · positive published findingsOpen study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed →
Research organized by substance and finding
Browse 21 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked substance to move directly to its corresponding Sunridge page.
Open study on PubMed →
Machine learning-powered discovery of a novel berberine derivative inducing SCD-dependent ferroptosis in osteosarcoma.
Although berberine (BBR) shows anti-tumor activity, its efficacy is limited.
Curcumin and Methotrexate: A Promising Combination for Osteosarcoma Treatment via Hedgehog Pathway Inhibition.
Curcumin (CUR)-with antioxidant and anti-cancer properties-downregulates Hh components in cancer, inhibiting progression.
Curcumin induces ferroptosis and apoptosis in osteosarcoma cells by regulating Nrf2/GPX4 signaling pathway.
The results showed that curcumin effectively decreased cell viability and increased apoptosis rate.
Mitochondria-Targeting Polymer Micelle of Dichloroacetate Induced Pyroptosis to Enhance Osteosarcoma Immunotherapy.
We synthesized a mitochondria-targeting polymer micelle (OPDEA-PDCA), in which poly[2-(N-oxide-N,N-diethylamino)ethyl methacrylate] (OPDEA) was used to target mitochondria and the conjugated dichloroacetate (DCA) was used to inhibit pyruvate dehydrogenase kinase 1 (PDHK1).
Epigallocatechin-3-gallate suppresses the growth of human osteosarcoma by inhibiting the Wnt/β-catenin signalling pathway.
Here, cellular experiments showed that EGCG significantly promoted OS cell apoptosis and inhibited proliferation, migration and invasion, and cell and animal experiments demonstrated that the Wnt/β-catenin pathway played an indispensable role in the antitumour effects of EGCG.
Repurposing Ivermectin to augment chemotherapy's efficacy in osteosarcoma.
Ivermectin also significantly inhibited osteosarcoma growth in vivo and its combination with doxorubicin resulted in much greater efficacy than doxorubicin alone.
Melatonin attenuates bone cancer pain via the SIRT1/HMGB1 pathway.
Moreover, mice in the melatonin group exhibited an increase in SIRT1 and nucleus-HMGB1, whilst there was a decrease in HMGB1, cytoplasm-HMGB1, rage, acetyl-HMGB1 and inflammatory cytokines compared with those in BCP mice.
Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin.
In addition, qRT-PCR results showed that the expressions of miR-181 and P53, CYLD, CBX7 and BCL2 genes change in MG63 cells after treatment with the combination of cisplatin and melatonin, so that the expression of P53, CYLD and CBX7 increased and the expression of BCL2 and miR-181b decreases significantly.
Inhibition of osteosarcoma by European Mistletoe derived val-miR218.
This study aimed to investigate whether mistletoe miRNAs, specifically val-miR218, exert anti-cancer activity against osteosarcoma.
Butyrate derived from intratumoral microbiome facilitates pulmonary metastasis in osteosarcoma.
Here, we integrated multiomics integration of 16S rRNA sequencing and circulating microbial DNA (cmDNA) profiling to investigate intratumoral microbiome dynamics in osteosarcoma pulmonary metastasis.
Gut microbiome and serum metabolome alterations in osteosarcoma patients.
Gut microbiota has been shown to initiate tumorigenesis and cancer metastasis in multiple cancer types.
Oral microbiota distinguishes patients with osteosarcoma from healthy controls.
The human microbiota plays a key role in cancer diagnosis, pathogenesis, and treatment.
Oxymatrine and Gut Microbiota Modulation: A Potential Therapeutic Strategy for Bone Cancer Pain Management.
BCP significantly altered gut microbiota composition and reduced serum and brain tissue butyric acid levels.
[Effect of rapamycin and chloroquine on osteosarcoma].
The xenograft model also confirmed that rapamycin combined with chloroquine had a better antitumor effect than single usage (relative tumor proliferation rate; T/C%.CQ: 98.4%±11.6%; RAPA: 65.5%±7.5%; CQ+ RAPA: 42.0%±3.4%).
Effects of rapamycin on osteosarcoma cell proliferation and apoptosis by inducing autophagy.
Compared with the Control group, Rapamycin group, and Rapamycin + Beclin-1 plasmid transfection group had markedly weakened the viability of MG-63 cells, inhibited cell proliferation, remarkably increased cell apoptosis rate, elevated Bax level, notably declined Bcl-2 level, and significantly raised the levels of Beclin-1 and Vps34 proteins in MG-63 cells.
Phosphatidylinositol 3-kinase and mechanistic target of rapamycin dualinhibitor, VDC597, as a therapeutic agent for canine osteosarcoma.
The results of this study demonstrate reduced signal transduction; increased cell death; reduced cell proliferation, migration, invasion, and vascular endothelial growth factor production in vitro; as well as reduced tumor growth and greater survival times with inhibition of PI3K-AKT-mTOR signaling in a xenograft mouse model.
Multiple Effects of Resveratrol on Osteosarcoma Cell Lines.
We found (1) a cell growth inhibition due to an increase in cell distress, which was, in part, due to the involvement of the AKT and caspase-3 pathways, (2) an increase in cellular differentiation due to major gene expression levels of the osteoblastic differentiation genes, (3) an inhibition of IL-6 secretion due to an epigenetic effect on the IL-6 promoter, and (4) an inhibition of OS cells migration related to the decrease in IL-8 secretion levels due to an epigenetic effect on its promoter.
RETRACTION: Resveratrol Derivative, Trans-3, 5, 4'-Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS-Induced Caspases Activation.
The study reports rETRACTION: Resveratrol Derivative, Trans-3, 5, 4'-Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS-Induced Caspases Activation.
Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin.
Co-treatment with ascorbate induced greater suppression of OS cell but not nonmalignant cell proliferation.
Vitamin D Represses the Aggressive Potential of Osteosarcoma.
1,25(OH)2D and the vitamin D receptor (VDR) suppress c-Myc function through regulating the c-Myc/MXD1 network and thus, providing a molecular basis of 1,25(OH)2D related to the cancer-preventive actions.
No studies match those filters. Clear a filter or try a broader term.